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Abstract
Despite the critical importance of proper cell cycle regulation in establishing the correct morphology
of organs and tissues during development, relatively little is known about how cell proliferation is
regulated in a tissue-specific manner. The control of cell proliferation within the developing heart is
of considerable interest, given the high prevalence of congenital cardiac abnormalities among
humans, and recent interest in the isolation of cardiac progenitor populations. We therefore review
studies exploring the contribution of cell proliferation to overall cardiac morphology and the
molecular mechanisms regulating this process. In addition, we also review recent studies that have
identified progenitor cell populations within the adult myocardium, as well as those exploring the
capability of differentiated myocardial cells to proliferate post-natally. Thus, the exploration of
cardiomyoctye cell cycle regulation, both during development as well as in the adult heart, promises
to yield many exciting and important discoveries over the coming years.
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During development, processes such as cell fate specification, proliferation, migration, and
cell death, must occur in a coordinated fashion. The failure of any of these processes during
embryogenesis can lead to developmental abnormalities, while the mis-regulation of many of
the same pathways in adulthood is associated with disorders such as cancer. Thus,
understanding the cellular and molecular mechanisms of development can provide crucial
insight into human health. The mechanisms by which cell proliferation is regulated have been
extensively studied in single-cell eukaryotes such as yeast, as well as in cultured mammalian
cells. These studies have provided numerous valuable insights into how the different stages of
the cell cycle are regulated, as well as the mechanisms by which cells exit the cell cycle and
cease proliferating. Comparatively less is known about developmental regulation of cell
proliferation, and especially about how this is achieved in a tissue-specific manner. In recent
years, studies characterizing factors that regulate the cell cycle within the developing heart
have advanced our understanding of how the morphology of the vertebrate heart is established
and broadened our knowledge of cell cycle control in early development.
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CELL CYCLE REGULATION DURING DEVELOPMENT
Much of what is known about the regulation of the cell cycle and DNA synthesis has been
studied primarily in yeast, mammalian cell culture, or in cell-free systems using Xenopus
oocyte extracts.1–6 During embryonic development, however, the cell cycle is modified by
extracellular signaling events, with some cell types exiting the cell cycle early in development,
and others continuing to proliferate extensively to adulthood. To address the in vivo
requirements for important cell cycle regulators during development, initial studies have been
carried out in Drosophila.7,8 For example, cyclins A and E, which were shown to promote cell
cycle progression in yeast and in Xenopus oocyte extract,5,6,9,10 are both necessary and
sufficient to initiate S-phase in Drosophila embryos, and are thereby essential for embryonic
development.8,11
More recently, studies have been undertaken in the mouse to determine the requirements for
various cell cycle regulators during vertebrate embryonic development (reviewed in ref. 12).
Surprisingly, despite the key role that cyclin/CDK complexes play during cell cycle
progression by phosphorylating and inactivating the cell cycle inhibitory factor, retinoblastoma
protein (Rb)13,14 (Fig. 1), individual cyclins and CDKs largely do not appear to be required
for normal embryonic development in mammals.15–18 For example, deletion of the G1 cyclins,
cyclin E1 and E2, does not affect embryo viability or cell cycle progression.15 This is in
contrast to Drosophila, where cyclin E is required for progression to S-phase, and its absence
results in embryonic lethality. Furthermore, knockout of all three mammalian D cyclins, cyclins
D1, D2 and D3, failed to cause widespread proliferation defects in mouse embryos,16 and mice
lacking both Cdk4 and Cdk6, which partner with the D cyclins to promote the initial
phosphorylation of Rb, are viable until late stages of gestation. In addition, deletion of Cdk2,
the binding partner of the E and A cyclins, does not result in major cell cycle defects in vivo.
19 Only the combined knockout of Cdk2 and Cdk4 has been shown to result in defects in cell
cycle progression and loss of Rb phosphorylation in vivo. These embryos only survive until
embryonic day (E) 15 in the mouse, and die primarily due to cardiac defects.20 Together, these
data suggest that a high level of compensation can occur between the different cyclins and
Cdks. The functional redundancy between the various cyclin/Cdk complexes is not total,
however, as other complexes cannot fully compensate for the loss of both Cdk2 and Cdk4.20
The unexpected degree of functional compensation between the cyclin/Cdk complexes in
mammalian embryos compared with what has been observed in yeast and in Drosophila
embryos underscores the importance of understanding how the cell cycle is regulated in the
context of a developing vertebrate embryo. Of particular interest is the observation that, while
knockouts of individual or various combinations of cyclins and Cdks do not necessarily cause
massive defects in cell proliferation throughout the embryo, deletion of each of these genes
results in subtle and tissue-specific defects. For example, deletion of Cdk4 affects primarily
pancreatic islet cells,21 while the loss of cyclin E results in a failure of endoreplication in
trophoblast giant cells,15 and deletion of cyclins D1, D2 and D3 primarily affects heart and
hematopoietic development.16 In contrast, targeted deletion in mice of cyclin A2, which is
required for both G1/S and G2/M transition, does result in early embryonic lethality at
E5.5.22 This suggests that despite the broad expression patterns of these cyclin/Cdk complexes,
the ability of remaining complexes to compensate for the loss of one or more cyclin/Cdks may
vary between cell and tissue types. Thus, further examination of tissue-specific cell cycle
regulation during development is necessary and will provide important insights into
organogenesis.
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OVERVIEW OF VERTEBRATE HEART FORMATION
In all vertebrate species, the heart is among the first organs to form, and the basic processes of
cardiac development are largely conserved.23 Two bilateral populations of cells on either side
of the midline of the embryo are induced into the cardiac lineage during gastrulation by signals
emanating from the anterior endoderm underlying the anterior lateral plate mesoderm and from
the organizer.24–27 Additionally, the poles of the heart tube gradually grow through the
addition of cells from a region contiguous with the splanchnic and core pharyngeal mesoderm,
and in mouse preferentially contribute cardiomyoctes in the case of the anterior heart field to
the proximal outflow tract and right ventricle and in the case of the secondary heart field to the
distal region of the outflow tract.28–31
Following induction, the two bilateral populations of cardiac precursors migrate to the midline
of the embryo where they fuse and form the linear heart tube composed of both an outer
myocardial layer, which will form the beating heart muscle, and an inner endocardial layer,
which will form the endothelial layer of the heart contiguous with the vasculature (reviewed
in refs. 23 and 32). Once the bilaminar heart tube has formed, the heart begins the process of
rightward looping, which will ultimately generate the distinct chambers of the heart.33
Mammalian and avian hearts are comprised of two atria and two ventricles (Fig. 2), while
amphibians have a three chambered heart with a single ventricle, and the heart of fish consists
of a single atrium and ventricle.
During cardiac looping, the ventral portion of the heart tube rotates to form the outer curvature
of the heart, with the dorsal side becoming the inner curvature.34 The chambers of the
myocardium form out of the outer curvature through a process of rapid cell proliferation and
increased cell size,35 while the cells of the inner curvature become the nonchamber
myocardium of the atrioventricular canal (AVC) and outflow tract (OFT), which will play a
role in the alignment and septation of the cardiac chambers.34
The early patterning of the myocardium is established, in part, by differential expression of
cardiac transcription factors, such as the T-box transcription factors TBX2, 3, 5 and 20, the
homeobox transcription factor NKX2.5, as well as GATA4, 5 and 6.32,34,36 Other chamber-
restricted cardiac transcription factors include HAND1 and HAND2 (also known as eHAND
and dHAND, respectively). In mammals, Hand1 and Hand2 are restricted to the left and right
ventricles, respectively, but are expressed ubiquitously in avian and amphibian hearts.37,38
The Iroquois homeobox genes (Irx) are also expressed in specific cardiac chamber primoridia.
39
The mechanisms by which these chamber-specific transcription factors promote cardiac
morphogenesis are only beginning to be understood. TBX2, TBX5, TBX20, HAND1, HAND2
and IRX4 have all been shown to be required for proper heart development, and they act both
individually and combinatorially to regulate the expression of other genes specific to distinct
regions of the developing myocardium,34,39–43 including atrial naturitic factor (ANF),44
Cited (also called Msg1),45 Chisel,46 connexin 40 and connexin 43.47 However, relatively
few targets of these chamber- restricted cardiac transcription factors have been identified, and
the precise cellular and molecular mechanisms by which they function remain unknown. The
polarity of the heart tube seen through the differential expression patterns of these and other
cardiac genes is later reinforced by changes in cell proliferation, polarity, and size.39 The roles
of some of these transcription factors in cardiomyocyte proliferation will be further explored
below.
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REGULATION OF CELL PROLIFERATION DURING EARLY CARDIAC
DEVELOPMENT
As mentioned above, cell proliferation plays a key role in heart formation. Following the initial
induction of cardiac precursor cells in vertebrate embryos, the cells undergo a period of rapid
proliferation beginning at about E8 in the mouse.27,48,49 Proliferation within the heart field
then transiently slows, followed by a second peak of proliferation at E11.48 However, the
molecular mechanisms regulating these waves of proliferation within the cardiac mesoderm
are poorly understood.
The early period of proliferation in the cardiac mesoderm corresponds with the close
association between the endoderm and the cardiac progenitor population.25 During this time,
cardiac cells continue to be exposed to a variety of growth factors and mitogens, including
fibroblast growth factors (FGFs) and bone morphogenic proteins (BMPs). In particular, studies
carried out in avian embryos have demonstrated that Fgf8, expressed in the endoderm
contacting the cardiac mesoderm, is required for the maintenance of Nkx2.5 and Mef2c
expression.49 FGF signaling has also been implicated in cardiac cell proliferation specifically
during this developmental window. Several studies have demonstrated that FGFs 1, 2 and 4,
which are expressed beginning at gastrulation in the endoderm underlying the heart-forming
field, are required for cardiac cell proliferation in explants of the avian cardiac mesoderm.
50–52 Additionally, a retro-viral vector encoding a dominant negative form of FGF receptor
1 (FGFR1) resulted in reduced cardiac cell proliferation when infected at day 3 and assessed
at day 7 of avian development, demonstrating a requirement for FGF signaling in cardiac cell
proliferation in vivo at stages corresponding to early cardiac morphogenesis. In contrast, no
effect on cardiac cell proliferation was observed when hearts were infected at day 7 and
observed at day 14.53 Together, these data suggest a role for FGF signaling in regulating the
high levels of cardiac cell proliferation observed during the early stages of cardiac migration,
heart tube formation, and cardiac looping.48 Moreover, the reduction in cardiac proliferation
that occurs after stage 24 in chick (approx. E12 in mouse), corresponds closely with reduced
expression of FGFs within the myocardium.52
BMPs are also present in the early heart field and myocardium during the same developmental
window as FGFs. Together with FGF signaling, BMP signaling also plays a role in the induction
and maintenance of early cardiac progenitor cells.54 BMP2, expressed in the anterior
endoderm, is required for the induction of cardiac progenitors in early heartfield explants,55
and together with FGF4, is sufficient to induce noncardiac mesoderm to produce heart tissue.
56 BMP signaling downstream of Gata6 also appears to be required after the initial induction
of cardiac progenitors for the maintenance of early cardiac genes, including Nkx2.5.57 Later
in development, BMPs function to promote the proliferation of the myocardium, as mice
lacking BMP receptor 1A exhibit a thin myocardial wall,58 while mice lacking the BMP
antagonist Noggin display hyperplastic growth of the ventricular myocardium.59
CELL PROLIFERATION AND CARDIAC CHAMBER FORMATION
In spite of the reduction in cell proliferation that occurs during cardiac chamber formation and
remodeling, cell proliferation plays a critical role throughout heart morphogenesis. The high
levels of DNA synthesis observed in the early cardiac mesoderm and myocardium are thought
to be important both for the expansion and segmentation of the heart tube along its anterior-
posterior axis, as well as for the formation of the cardiac chambers.34,35
Recent studies of the basic-helix-loop-helix transcription factor HAND1 underscore the
importance of proper regulation of the early cardiomyocyte cell cycle in establishing the correct
length of the early heart tube. Loss of function and overexpression studies support a role for
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HAND1 in promoting the proliferation of cardiomyocyte progenitor cells prior to terminal
differentiation.60–62 Deletion of Hand1 from the developing heart results in shortening of the
outflow tract as well as hypoplasia of the right ventricle, resulting in the formation of an
unlooped heart tube.62 In contrast, overexpression of Hand1 within the developing heart tube
has the opposite effect, where the outflow tract is lengthened due to increased cell proliferation,
resulting in abnormal cardiac looping, and overall abnormal cardiac morphology.61 Thus,
regulation of cardiomyocyte cell proliferation by HAND1 plays a necessary and sufficient role
in establishing the correct length of the early heart tube, thereby contributing to the process of
cardiac looping.
In addition to a requirement for the correct number of cells in order to generate a heart tube of
the proper length, recent analysis suggests that the orientation of cell divisions plays a key role
in cardiac morphogenesis. Retrospective clonal analysis of the developing mammalian heart
has revealed two distinct phases of myocardial proliferation.63 In the first phase, which
corresponds to the formation and elongation of the heart tube during early stages of cardiac
development (prior to E8.5), descendents of individual labeled cells are observed to disperse
over fairly long ranges, and always along the arteriovenous axis. Thus, this phase is termed the
dispersive phase.63
In the second phase, which begins after E8.5, clonal cells form larger clusters. This latter phase
has been termed the coherent phase of growth, and further analysis has revealed that coherent
clones have a distinct orientation of growth that corresponds with the chamber in which they
reside.63 For example, clones in the outflow tract take on a linear anterior-posterior orientation,
while clones in the left ventricle tend to radiate out from the AVC.63,64 This work provides
evidence that the orientation of cell division, as well as the rate of proliferation, plays a critical
role in generating the correct pattern and shape of the developing heart.
In further support of these findings, several zebrafish mutants have been identified that have
severe cardiac abnormalities due to the failure of myocardial cells to divide along the proper
axis. These include the mutants santa (san), valentine (vtn) and heart of glass (heg). San and
vtn encode zebrafish homologs of two genes associated with brain vasculature defects known
cerebral cavernous malformations in humans, CCM1 and CCM2 respectively,65 while heg
encodes a novel, membrane-bound signaling protein expressed in the endocardium.66 The
phenotype of each of these mutants is very similar, wherein the hearts are enlarged and exhibit
a thin ventricular wall due to the failure to add concentric layers to the myocardium. Normally,
these concentric layers are added when cardiac cells shift their orientation of cell division to
divide along the transmural axis (from the epicardium to the endocardium). Failure of this
process results in expansion of the myocardium only along the initial axis, leading to severe
morphological abnormalities and a failure of cardiac function.65,66 Thus, generating both the
correct number and orientation of cell divisions within the developing heart plays a critical role
in generating proper the morphology and function of this organ.
During the developmental stages when these patterns of oriented cell divisions are being
established within the myocardium, differential levels of cell proliferation are also observed
in different regions of the myocardial tube. Increased levels of cell proliferation are observed
in the presumptive chamber myocardium of the atria and ventricles, as compared with the non-
chamber myocardium of the OFT and AVC.34 The mechanisms by which cell proliferation is
differentially regulated between the chamber myocardium and non-chamber myocardium are
not well characterized, however some recent studies have begun to elucidate this process.
The early cardiac chambers of the vertebrate heart are initially formed by increased levels of
proliferation in the presumptive chamber myocardium compared with non-chamber
myocardium of the heart tube. This results in the “ballooning” out of the chamber myocardium.
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34,35 Prior to this expansion, chambers are specified in part by the activity of cardiac T-box
transcription factors. Tbx5 exhibits a graded expression pattern along the anterior-posterior
axis of the heart tube, with the highest levels of expression seen in the future atria and left
ventricle (common ventricle in amphibians),34,42 while Tbx20 is expressed throughout the
developing myocardium.67–69 In concert with NKX2.5, these two transcription factors
promote the formation of the chamber myocardium by activating expression of chamber-
specific genes. In addition, TBX5 and TBX20 have been shown to physically and functionally
interact with one another,40 suggesting that they may function together to regulate
cardiomyocyte cell number as well as gene expression within the developing heart.
In the non-chamber myocardium, the activity of TBX5 and TBX20 is opposed by the
transcriptional repressors TBX2 and TBX3,43 which are thought to compete with TBX5 for
binding to NKX2.5.70 Furthermore, TBX20 has been shown to repress Tbx2 expression within
the chamber myocardium, as loss of TBX20 results in increased Tbx2 expression throughout
the heart tube.71,72 Interestingly, TBX2 has been shown to repress transcription of N-myc, a
protein required for G1/S transition in cardiac and other cell types.73 Deletion of Tbx20 thereby
results in decreased expression of N-myc, hypoplasia of the myocardium, and a resultant failure
of cardiac morphogenesis.71,72 Furthermore, TBX5 has been shown to be required for cardiac
cell cycle progression, specifically at the G1/S transition.74 These data support a model of
cardiac chamber formation whereby cell proliferation is maintained at low levels in the non-
chamber myocardium by the transcriptional repressor activity of TBX2, while high levels of
proliferation are promoted in the chamber myocardium by the activity of TBX5 and TBX20,
either by repressing the activity of factors that inhibit cell cycle progression, or by directly
promoting cell cycle progression (Fig. 3).
CARDIOMYOCYTE PROLIFERATION AND VENTRICULAR REMODELING
In addition to a role in chamber formation, cardiac cell proliferation is also important for the
remodeling of the ventricles as the compact and trabecular layers of the myocardium are
distinguished. Remodeling of the ventricles begins at the end of the cardiac looping stage75,
76 (E10.5 in mouse, HH stage 18 in chick, and Nieuwkoop and Faber stage 37 in Xenopus).
The trabeculae of the ventricle are finger-like bundles of cardiomyoctyes that project into the
chamber of the ventricle by about E10.5 in mouse. By contrast, the compact myocardium
consists of cardiac myocytes that are more densely organized, forming the outer wall of the
myocardium. The trabecular myocardium provides most of the contractile force during early
embryonic heart function, while later in heart development this role shifts to the compact
myocardium.75 In addition to distinct cellular organization, the two myocardial layers also
differ in their mitotic activity, with the compact myocardium being more highly proliferative
overall, thereby driving the growth of the embryonic heart, and the trabecular myocardium
proliferating at a much lower rate.76 The timing of cell proliferation also differs between the
compact and trabecular myocardium. The mitotic index (MI) of the trabecular layer reaches
peak levels at E10.5 and declines rapidly, while in the compact layer, the MI peaks between
E9.5 and E11.5 and declines more gradually.77
The fate of ventricular cardiomyocytes to become either compact or trabecular myocardium
appears to be governed, at least in part, by signals emanating from the epicardium78–80 and
endocardium respectively.79,81–83 Retinoic acid and other yet unidentified signals from the
epicardium play a role in instructing myocardial cells to become compact myocardium.79 The
trabecular myocardium is patterned by neuregulin secreted from the endocardium and its
downstream effectors, which induce these cell to form projections into the lumen of the heart
tube.81–83 Once this patterning is established, it is reinforced by the differential levels of
proliferation observed between the compact and trabecular myocardium. The relatively higher
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levels of proliferation in the compact myocardium are promoted primarily through FGF
signaling downstream of retinoic acid secreted from the epicardium.79,80
Recently, several transcription factors have been identified that play important roles in cardiac
morphogenesis by negatively regulating proliferation in the trabecular myocardium. The gene
jumonji (jmj), which encodes a member of the AT-rich interaction domain (ARID) family of
transcription factors, was found to negatively regulate the cell cycle, with over-proliferation
observed in hearts of embryos lacking jmj.84 The timing of jmj expression in trabecular and
compact myocardium of the ventricle matches the time points at which each begins to reduce
their respective MI.77 JMJ has been shown to function in part by repressing cyclin D1
expression in the trabecular myocardium77 and can also physically interacts both with NKX2.5
and GATA4. This results in repression of ANF in the AVC,85 suggesting that JMJ may play
a role in establishing chamber identity in addition to its function in regulating cell cycle
progression. This finding further supports a link between molecules that establish cardiac
chamber identity and those that are required for cell proliferation within the developing heart.
Other transcription factors that act to restrict cardiac cell proliferation within the ventricular
trabeculae include FOXP1, a member of the winged helix family of transcription factors,86
and HOP1, an unusual homeobox-containing protein.87,88 An increase in cell proliferation
has been observed in the trabecular zone of Foxp1 null embryos, however, Foxp1 is expressed
primarily in the compact myocardium and the mechanism by which it acts to restrict
proliferation in the trabeculae has not been established.86 The hearts of HOP1 null mice exhibit
thickened ventricular walls in comparison with wild-type littermates, due primarily to an
increase in cell number. HOP1 appears to be expressed primarily within the trabecular
myocardium of the ventricle, and was shown to physically interact with Serum Response Factor
(SRF). One molecular function of HOP1 is to antagonize the activity of SRF,87,88 however,
the exact molecular mechanism by which HOP1 acts to inhibit cardiac cell cycle progression
is not yet known. Thus, further analysis of how tissue-specific transcription factors interact
with, and regulate the cell cycle machinery during development is crucial to the understanding
of how specific organs are patterned and how they achieve their required size and function.
THE RELATIONSHIP BETWEEN PROLIFERATION AND CARDIAC
DIFFERENTIATION
In many tissues, such as muscle and the nervous system, the withdrawal of cells from the cell
cycle is tightly associated with the onset of terminal differentiation.89–92 In contrast, relatively
little is known about the relationship between cell cycle progression and terminal
differentiation in the heart. Myocardial cells continue to proliferate until just after birth in
mammals, when nearly all exit the cell cycle.48 As a result of this cell cycle exit,
cardiomyocytes in the adult heart are thought to be very limited in their regenerative capacity.
In skeletal muscle, by contrast, associated muscle progenitor cells, termed satellite cells, retain
the ability to proliferate and differentiate into mature muscle upon injury.93
Mutations in a number of genes that are required for cell cycle progression in the heart also
result in defects in cardiac differentiation. Hand1 is required, primarily in the OFT and left
ventricle, for cell cycle progression at the G1/S transition by promoting the transcription of
cyclin D2 and Cdk4.61 Over-expression of Hand1 in the developing heart results in increased
cardiac cell proliferation as well as delayed and reduced expression of cardiac differentiation
markers.61 In addition, deletion of jmj, which promotes cell cycle exit by repressing cyclin D1
expression,77 results in reduced expression of cardiac differentiation markers as well as
increased proliferation within the heart.84 These experiments lend support to a close
association between cell cycle exit and terminal differentiation in myocardial cells, as has been
demonstrated for other cell types. However, the consequences of disrupting the cell cycle upon
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cardiomyocyte differentiation during development have never been directly examined, leaving
open the possibility that cell cycle exit is not directly linked with terminal differentiation within
the heart. Supporting this possibility is the observation that cell proliferation continues within
the developing myocardium even after the fully differentiated, beating heart has formed, with
myocardial cells ultimately exiting the cell cycle after birth.48 In addition, work done in
Xenopus has shown that in embryos at the tadpole stage, cells within the myocardium bearing
structural hallmarks of differentiated cardiomyocytes stain positively for phosphohistone H3,
a marker of M phase of the cell cycle.74 Together, these data suggest that vertebrate
cardiomyoctyes retain the ability to divide as they undergo terminal differentiation.
The potential for cells of the adult vertebrate myocardium to proliferate has generated
considerable interest in recent years (reviewed in refs. 48, 94 and 95). Several reports have
indicated that rare cardiac progenitor cells exist within the mammalian myocardium. These
progenitor populations are positive for distinct sets of markers, and were isolated from hearts
at different stages, including embryonic, neonatal, and adult hearts.96–100 One population of
progenitor cells isolated from embryonic hearts and positive for the secondary heart field
marker islet1 is capable of forming fully differentiated cardiomyocytes in culture,98 and is
also capable of differentiating into endothelial and smooth muscle cells.99 cKit+ cells with the
ability to differentiate into cardiomyoctes have been identified both in adult and embryonic
hearts.96,100 Finally, a Sca1+ population of cells in the adult myocardium is also capable of
differentiating into cardiomyocytes when isolated from the heart and cultured in vitro, as well
as when transplanted into mice with ischemia/reperfusion injuries.97 Thus, despite the fact
that cardiomyocytes begin to exit the cell cycle during embryonic development following the
onset of differentiation, and that most myocardial cells exit the cell cycle shortly after birth,
one or more populations of undifferentiated cardiac progenitor cells exist in both the embryonic
and adult myocardium. However, the molecular pathways by which these cells are specified
and maintained within the heart during development are largely unknown.
Given the thereputic implications of cardiomyocyte regeneration for the treatment of
pathological conditions such as myocardial infarction, the ability of differentiated adult
myocardial cells to enter the cell cycle has been the subject of considerable research and
controversy. It has been demonstrated, for example, that differentiated cardiomyoctyes
continue to undergo DNA replication, as shown by incorporation of BrDU.101 However, this
may be indicative of the round of endoreplication that is known to occur in post-mitotic
cardiomyocytes.48,101 Very low percentages of adult human cardiomyoctyes have been
observed to express markers associated with M-phase- approximately 14 myocytes per million.
102 Several lines of evidence also suggest that cardiomyocytes may have some capacity to
reenter the cell cycle upon injury. Increased numbers of proliferating cardiomyocytes are
observed in the hearts of patients who died of heart failure,102 and in another study, even
higher percentages of M-phase cardiomyocytes were observed adjacent to myocardial
infarction sites.103 More recent work has also suggested that over-expression of cyclin D2 in
a mouse model of myocardial infarction promotes increased DNA synthesis in the injured
hearts and leads to regression of the infarction.104 Thus, the capacity of cells within the adult
myocardium to proliferate, as well as factors that might promote cardiomyocyte cell cycle in
response to injury are in need of further exploration.
CONCLUSIONS
Establishing the mechanisms by which cell proliferation is regulated in the developing heart
is of critical importance, both for our understanding of the cellular basis of cardiac
morphogenesis during embryonic development, as well as in establishing the origin and nature
of cardiac progenitor cell populations existing in the adult myocardium. Cell proliferation
levels within the developing myocardium appear to be highly specific to a given region and
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developmental stage of the embryonic heart, thus playing an important role in the shaping and
pattering of the heart.35 Furthermore, not only are the levels of cell proliferation important,
but the plane of cell division within the myocardium also appears to have a key function in
morphogenesis.63–66 The factors required to establish these regionalized patterns of cell
proliferation within the heart, as well has how these patterns tie in with the identity of cardiac
chambers, are only now beginning to be characterized.
In addition, the discovery that several populations of cardiac progenitor cells with unique
properties exist within the postnatal and adult heart has lead to an important shift from the view
that the mammalian adult myocardium is entirely post-mitotic with little to no regenerative
capacity.95 Thus, understanding how these populations are set aside during development and
characterizing the signals that regulate their proliferation and differentiation is of crucial
importance in regenerative medicine.
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Molecular regulation of the G1/S transition. A schematic of the major molecular pathways both
promoting and inhibiting the progression from G1 to S-phase of the cell cycle. Growth factors
promote entry into S phase by inducing expression and activity of cyclin D, cyclin E and their
associated Cdks. These complexes in turn phosphorylate and inactivate the retinoblastoma
protein (Rb), which then releases E2F, a transcription factor upstream of many other cell cycle-
promoting factors, as well as DNA replication factors. Cell cycle progression can be inhibited
by growth inhibitory signals, or by DNA damage, which results in p53 expression. Both of
these pathways result in increased expression of Cdk inhibitors such as p21 and p27, which
antagonize activity of the Cyclin/Cdk complexes, inhibiting entry into S-phase.
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Development of the vertebrate heart. A schematic depiction of vertebrate heart morphogenesis
(based on the mouse) at the equivalent of mouse E7.5 (A), E8.5 (B), E9.5 (C), and E11.5 (D).
OFT, outflow tract; RV, right ventricle; LV, left ventricle; A, atria; AO, aorta; SV, sinus
venosus; RA, right atrium; LA, left atrium.
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T-box transcription factors and the development of the chamber and non-chamber
myocardium. In the non-chamber myocardium (orange), TBX2 represses transcription of ANF
and other genes specific to the chamber myocardium, and out-competes TBX5 for binding to
NKX2.5 within the inner curvature. TBX2 also represses N-myc, a transcription factor that
promotes cell proliferation, keeping proliferation levels low in the non-chamber myocardium.
In the chamber myocardium (red), TBX5 binds to the ANF promoter and promotes its
transcription. In addition, expression of TBX2 is repressed by TBX20, thus relieving repression
of N-myc. Together with higher levels of TBX5 expression, which promotes cell cycle
progression, this leads to higher levels of cell proliferation within the chamber myocardium.
OFT, outflow tract; IC, inner curvature; V, ventricles; A, atria.
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